Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 300 (RNA5SP300)

Target
RNA5SP300
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 300 (RNA5SP300) is classified as a non-coding RNA pseudogene, specifically an rRNA pseudogene predicted by genome annotation pipelines. It is related by sequence to canonical 5S ribosomal RNA genes, which encode the 5S component of the large ribosomal subunit, a critical structural RNA in ribosomes across eukaryotes and prokaryotes. However, unlike active 5S rRNA genes, RNA5SP300 is presumed nonfunctional due to mutations that prevent it from producing a functional RNA molecule or from participating in ribosome biogenesis. While some pseudogenes are transcribed and may have regulatory or antisense functions at the RNA level, there is no evidence that RNA5SP300 has any documented biological activity, clinical relevance, or utility as a drug target or biomarker in humans. It is primarily noted as part of the large group of dispersed 5S rRNA pseudogenes within the genome, and not as a protein, enzyme, receptor, transporter, or therapeutic target.

Other names
RN5S300RNA, 5S ribosomal 300RNA5SP300
02

Biological functions

No direct function as a protein/enzyme/receptorMay act in regulation at the RNA level (as with some pseudogenes), but function for this specific pseudogene is not documented
03

Disease associations

No established direct roleIn general, pseudogenes can sometimes participate in regulatory networks, but no evidence is present for this specific gene

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 300 (RNA5SP300).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 300 (RNA5SP300).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call